These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 13130390)
61. Polysomnographic effects of adjuvant ginkgo biloba therapy in patients with major depression medicated with trimipramine. Hemmeter U; Annen B; Bischof R; Brüderlin U; Hatzinger M; Rose U; Holsboer-Trachsler E Pharmacopsychiatry; 2001 Mar; 34(2):50-9. PubMed ID: 11302564 [TBL] [Abstract][Full Text] [Related]
62. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial. Cumbo E; Ligori LD J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733 [TBL] [Abstract][Full Text] [Related]
64. Predictors of home discharge among patients hospitalized for behavioural and psychological symptoms of dementia. Tochimoto S; Kitamura M; Hino S; Kitamura T Psychogeriatrics; 2015 Dec; 15(4):248-54. PubMed ID: 25919794 [TBL] [Abstract][Full Text] [Related]
65. Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS). Matsuzono K; Sato K; Kono S; Hishikawa N; Ohta Y; Yamashita T; Deguchi K; Nakano Y; Abe K J Alzheimers Dis; 2015; 48(3):757-63. PubMed ID: 26402119 [TBL] [Abstract][Full Text] [Related]
66. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598 [TBL] [Abstract][Full Text] [Related]
67. Cognitive and other behavioral effects of EGb 761 in animal models. Müller WE; Chatterjee SS Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S24-31. PubMed ID: 13130385 [TBL] [Abstract][Full Text] [Related]
68. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. Iwasaki K; Satoh-Nakagawa T; Maruyama M; Monma Y; Nemoto M; Tomita N; Tanji H; Fujiwara H; Seki T; Fujii M; Arai H; Sasaki H J Clin Psychiatry; 2005 Feb; 66(2):248-52. PubMed ID: 15705012 [TBL] [Abstract][Full Text] [Related]
69. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication]. Blume J; Kieser M; Hölscher U Vasa; 1996; 25(3):265-74. PubMed ID: 8967154 [TBL] [Abstract][Full Text] [Related]
70. Characteristics of behavioral and psychological symptoms of dementia, severity and levels of distress on caregivers. Taemeeyapradit U; Udomittipong D; Tepparak N J Med Assoc Thai; 2014 Apr; 97(4):423-30. PubMed ID: 24964685 [TBL] [Abstract][Full Text] [Related]
71. Vasodilators and nootropics as predictors of dementia and mortality in the PAQUID cohort. Dartigues JF; Carcaillon L; Helmer C; Lechevallier N; Lafuma A; Khoshnood B J Am Geriatr Soc; 2007 Mar; 55(3):395-9. PubMed ID: 17341242 [TBL] [Abstract][Full Text] [Related]
72. Moderating effect of self-efficacy on the relation between behavior problems in persons with dementia and the distress they cause in caregivers. Nogales-González C; Romero-Moreno R; Losada A; Márquez-González M; Zarit SH Aging Ment Health; 2015; 19(11):1022-30. PubMed ID: 25559886 [TBL] [Abstract][Full Text] [Related]
73. Dopamine D3 receptor gene polymorphism influences on behavioral and psychological symptoms of dementia (BPSD) in mild dementia of Alzheimer's type. Sato N; Ueki A; Ueno H; Shinjo H; Morita Y J Alzheimers Dis; 2009; 17(2):441-8. PubMed ID: 19363270 [TBL] [Abstract][Full Text] [Related]
74. Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): frequency and relationship with disease severity and motor impairment. Borroni B; Agosti C; Padovani A Arch Gerontol Geriatr; 2008; 46(1):101-6. PubMed ID: 17467082 [TBL] [Abstract][Full Text] [Related]
75. Treatment of behavioral and psychological symptoms of dementia: a systematic review. Preuss UW; Wong JW; Koller G Psychiatr Pol; 2016; 50(4):679-715. PubMed ID: 27847922 [TBL] [Abstract][Full Text] [Related]
76. [Delay in progression of dependency and need of care of dementia patients treated with Ginkgo special extract EGb 761]. Haan J; Hörr R Wien Med Wochenschr; 2004 Nov; 154(21-22):511-4. PubMed ID: 15638069 [TBL] [Abstract][Full Text] [Related]
77. Advantages of different care services for reducing neuropsychiatric symptoms in dementia patients. Suzuki Y; Kazui H; Yoshiyama K; Azuma S; Kanemoto H; Sato S; Suehiro T; Ikeda M Psychogeriatrics; 2018 Jul; 18(4):252-258. PubMed ID: 29417692 [TBL] [Abstract][Full Text] [Related]
78. [Tanakan (EGb 761) in the therapy of mild cognitive impairment]. Iakhno NN; Zakharov VV; Lokshina AB; Gavrilova SI; Fedorova IaB; Gustov AV; Korshunova IuA; Dziak LA; Miziakina EV; Odinak MM; Emelin AIu; PilipenkoP I ; Vostrikova EV Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(12):41-6. PubMed ID: 17274394 [TBL] [Abstract][Full Text] [Related]